Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

SQI Diagnostics Inc V.SQD.H

SQI Diagnostics Inc. is a Canada-based company that is focused on lung health. The Company is engaged in the development and manufacturing of respiratory health and precision medicine tests that run on its fully automated systems. Its clinical solutions include Rapid Acute Lung Injury Diagnostic (RALI-Dx), lung transplant diagnostics, COVID-19 testing and surveillance testing solutions. Its RALI-Dx IL-6 Severity Triage Test and the RALI-fast IL-6 Severity Triage point of care (POC) Test each help clinicians identify which patients with SARS-CoV-2 are predicted to have a severe inflammatory response and should or should not be admitted to the hospital. Its RALI-Dx delivers results from the lab in less than an hour while RALI-fast delivers results at the patient point-of-care in about 15 minutes. The Company’s TORdx LUNG Test measures inflammation at the molecular level to assess the health of the donor lung. The Company is also focused on its organ transplant pipeline of products.


TSXV:SQD.H - Post by User

Post by ResearchGuyon Dec 15, 2021 9:04pm
213 Views
Post# 34235205

Autoimmune Disease Diagnostic Market

Autoimmune Disease Diagnostic Market

As per the Digital Journal dated December 15, 2021 the projected Autoimmune Disease Diagnostic Market in North America alone is projected to increase by almost 6 billion dollars by 2027. 

"Transparency Market Research (TMR) has published a new report titled, ‘Autoimmune Disease Diagnostics Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2027’. According to the report, the global autoimmune diagnostic disease disgnostic market was valued at US$ 14.4 Bn in 2018 and is projected to expand at a CAGR of 3.8% from 2019 to 2027."

The article highlights several categories within the Antoimmune Disease Disgnostic Industry that will see exponential growth and explains why. 

Several sectors in specific that peaked my interest is the mentioning of Antibody Testing. 

"Autoantibody Test Segment to Dominate Market"

"Rheumatoid Arthritis to be Highly Lucrative Segment"
 

The future looks promising for SQI.

https://www.digitaljournal.com/pr/autoimmune-disease-diagnostics-market-to-generate-revenue-of-us-20-1-bn-by-2027

 



 

<< Previous
Bullboard Posts
Next >>